Invention Grant
US08012697B2 Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma
失效
用于检测前列腺癌的单克隆抗膜联蛋白A3抗体
- Patent Title: Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma
- Patent Title (中): 用于检测前列腺癌的单克隆抗膜联蛋白A3抗体
-
Application No.: US12303825Application Date: 2007-06-11
-
Publication No.: US08012697B2Publication Date: 2011-09-06
- Inventor: Andre Schrattenholz
- Applicant: Andre Schrattenholz
- Applicant Address: DE Mainz
- Assignee: ProteoSys AG
- Current Assignee: ProteoSys AG
- Current Assignee Address: DE Mainz
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- International Application: PCT/EP2007/005134 WO 20070611
- International Announcement: WO2007/141043 WO 20071213
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/574 ; C07K16/00 ; C12P21/08
Abstract:
The present invention relates to a method for the diagnosis of prostate carcinoma comprising the determination of annexin A3, particularly of extracellular annexin A3 with highly specific antibodies, particularly with monoclonal antibodies. The present invention further refers to a test reagent comprising such antibodies.
Public/Granted literature
- US20100233160A1 Monoclonal Anti-Annexin A3 Antibodies for the Detection of Prostate Carcinoma Public/Granted day:2010-09-16
Information query
IPC分类:
